U.S. market Closed. Opens in 11 hours 25 minutes

HLVX | HilleVax, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue2.16M2.25M3.00KN/AN/A
Gross Profit-2.16M-2.25M-3.00KN/AN/A
Operating Expenses131.19M62.61M15.77M1.29M633.00K
Selling, General & Admin24.51M16.70M5.76M1.29M633.00K
Research & Development106.68M45.91M10.01MN/AN/A
Other Operating ExpensesN/A-94.70M-20.23M-779.00KN/A
Operating Income-133.34M-65.11M-53.43M-1.29M-633.00K
Other Expenses / Income9.78M-94.70M-48.98M-808.00K-40.00K
Before Tax Income-123.57M-159.81M-102.41M-2.10M-673.00K
Income Tax ExpensesN/A97.20M-17.38M29.00K-633.00
Net Income-123.57M-257.00M-85.03M-2.13M-673.00K
Interest Expenses2.39M3.41M2.84M29.00K9.00K
Basic Shares Outstanding40.60M37.66M30.19M30.19M30.19M
Diluted Shares Outstanding40.60M37.66M30.19M30.19M30.19M
EBITDA-131.19M-60.11M-35.99M-2.07M-633.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-121.17M-156.40M-99.56M-2.07M-664.63K
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙